[18F]DPA-714 is currently under investigation as a potential radiopharmaceutical for imaging TSPO in living systems using positron emision tomography (PET).
The 18 kDa translocator protein (TSPO) is an ideal target for neuroinflammation imaging.
![DPA-714](https://radboudtranslationalmedicine.nl/cdn/08e0a1a1-5ca4-4920-9e85-98094a3ebe5e/-/format/auto/-/quality/smart/dpa-714.png)
Interested in our products?
Contact us to discuss the possibilities.